Shandong Realcan Pharmaceutical Co Ltd (002589) — Financial Flexibility Index
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥6.75 Million (operating CF CN¥-15.60 Million minus capex CN¥22.35 Million) represents 0% of total liabilities (CN¥9.87 Billion). Check 002589 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Realcan Pharmaceutical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Shandong Realcan Pharmaceutical Co Ltd across 18 annual periods. See working capital position of Shandong Realcan Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Shandong Realcan Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Shandong Realcan Pharmaceutical Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | CN¥40.58 Million | CN¥13.76 Million | CN¥8.95 Billion | ▼ -82.8% |
| 2024 | 0.03x | CN¥271.97 Million | CN¥160.44 Million | CN¥10.32 Billion | ▼ -23.4% |
| 2023 | 0.03x | CN¥380.85 Million | CN¥82.47 Million | CN¥11.07 Billion | ▼ -37.7% |
| 2022 | 0.06x | CN¥694.04 Million | CN¥523.07 Million | CN¥12.58 Billion | ▲ +1.9% |
| 2021 | 0.05x | CN¥904.04 Million | CN¥442.95 Million | CN¥16.70 Billion | ▲ +27.3% |
| 2020 | 0.04x | CN¥920.35 Million | CN¥414.96 Million | CN¥21.65 Billion | ▼ -68.8% |
| 2019 | 0.14x | CN¥3.03 Billion | CN¥2.09 Billion | CN¥22.21 Billion | ▲ +697.0% |
| 2018 | 0.02x | CN¥402.66 Million | CN¥-201.66 Million | CN¥23.53 Billion | ▲ +114.5% |
| 2017 | -0.12x | CN¥-2.04 Billion | CN¥-2.42 Billion | CN¥17.31 Billion | ▲ +33.4% |
| 2016 | -0.18x | CN¥-1.44 Billion | CN¥-1.76 Billion | CN¥8.15 Billion | ▼ -170.4% |
| 2015 | -0.07x | CN¥-356.80 Million | CN¥-466.26 Million | CN¥5.46 Billion | ▼ -1383.3% |
| 2014 | 0.01x | CN¥19.63 Million | CN¥-163.62 Million | CN¥3.85 Billion | ▲ +111.8% |
| 2013 | -0.04x | CN¥-121.36 Million | CN¥-274.46 Million | CN¥2.80 Billion | ▼ -63.7% |
| 2012 | -0.03x | CN¥-58.27 Million | CN¥-170.52 Million | CN¥2.20 Billion | ▲ +91.7% |
| 2011 | -0.32x | CN¥-446.44 Million | CN¥-475.03 Million | CN¥1.40 Billion | ▼ -448.4% |
| 2010 | 0.09x | CN¥108.28 Million | CN¥70.56 Million | CN¥1.18 Billion | ▼ -8.6% |
| 2009 | 0.10x | CN¥80.62 Million | CN¥61.38 Million | CN¥805.78 Million | ▲ +419.2% |
| 2008 | -0.03x | CN¥-18.92 Million | CN¥-49.88 Million | CN¥603.64 Million | — |